This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Eli Lilly and Company. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Matthew William Carson: Innovator in Pharmaceutical Science
Introduction
Matthew William Carson is a notable inventor based in Fishers, IN (US). He has made significant contributions to the field of pharmaceutical science, particularly in the development of compounds for treating inflammatory and immune disorders. With a total of 2 patents to his name, Carson's work is recognized for its potential impact on healthcare.
Latest Patents
Carson's latest patents include a glucocorticoid receptor modulator and methods of use. The first patent provides Compound (I) or a pharmaceutically acceptable salt thereof, along with pharmaceutical compositions that comprise Compound (I) in combination with one or more pharmaceutically acceptable carriers, excipients, or diluents. This invention outlines methods for treating inflammatory and immune disorders by administering an effective amount of Compound (I) to patients in need.
The second patent focuses on (E)-N-{3-[1-(8-fluoro-11H-10-OXA-1-AZA-dibenzo [A,D] cyclohepten-5ylidene)-propyl]-phenyl}-methanesulfonamide as a glucocorticoid receptor modulator for the treatment of rheumatoid arthritis. Similar to the first, this patent also provides Compound (I) or a pharmaceutically acceptable salt thereof, detailing pharmaceutical compositions and methods for treatment.
Career Highlights
Matthew William Carson is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His work at Eli Lilly has allowed him to focus on innovative solutions for complex medical challenges.
Collaborations
Carson collaborates with Michael Joseph Coghlan, contributing to the advancement of pharmaceutical research and development. Their partnership exemplifies the collaborative spirit essential in the field of innovation.
Conclusion
Matthew William Carson's contributions to pharmaceutical science through his patents and work at Eli Lilly and Company highlight his role as an influential inventor. His innovative approaches to treating inflammatory and immune disorders continue to pave the way for advancements in healthcare.